Telix Pharmaceuticals

(NASDAQ) TLX

Current Price$10.54

Market Cap$3.58B

Since IPO (2024)-30%

5 YearN/A

1 Year-35%

1 Month-1%

Telix Pharmaceuticals Financials at a Glance

Market Cap

$3.58B

Revenue (TTM)

$2.00B

Net Income (TTM)

$39.18M

EPS (TTM)

$-0.02

P/E Ratio

-500.47

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$10.54

Volume

80,248

Open

$10.68

Price

$10.54

Volume

80,248

Open

$10.68

Previous Close

$10.56

Daily Range

$10.24 - $10.78

52-Week Range

$6.28 - $18.49

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$10.54

Volume

80,248

Open

$10.68

Previous Close

$10.56

Daily Range

$10.24 - $10.78

52-Week Range

$6.28 - $18.49

TLX News

1 Basically Unknown Stock That Could Turn Cancer‑Imaging Breakthroughs Into Generational Wealth

James HalleyFeb 26, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Telix Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

234

CEO

Christian P. Behrenbruch, PhD, EMBA

Website

www.telixpharma.com

Headquarters

North Melbourne, VIC 3051, AU

TLX Financials

Key Financial Metrics (TTM)

Gross Margin

51%

Operating Margin

Net Income Margin

-1%

Return on Equity

-2%

Return on Capital

Return on Assets

-1%

Earnings Yield

-0.20%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.58B

Shares Outstanding

339.38M

Volume

80.25K

Avg. Volume

247.71K

Financials (TTM)

Gross Profit

$640.23M

Operating Income

$26.64M

EBITDA

$79.83M

Operating Cash Flow

$25.93M

Capital Expenditure

$56.86M

Free Cash Flow

$82.80M

Cash & ST Invst.

$212.53M

Total Debt

$784.47M

Telix Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$620.44M

+120.2%

Gross Profit

$327.42M

+46.2%

Gross Margin

52.77%

N/A

Market Cap

$3.58B

N/A

Market Cap/Employee

$3.20M

N/A

Employees

1,120

N/A

Net Income

$7.25M

-137.1%

EBITDA

$28.92M

+25.8%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$571.94M

-640.6%

Accounts Receivable

$207.29M

+220.0%

Inventory

$55.55M

+220.9%

Long Term Debt

$756.51M

+4662.1%

Short Term Debt

$27.95M

+1692.9%

Return on Assets

-0.61%

N/A

Return on Invested Capital

1.81%

N/A

Free Cash Flow

$92.60M

-2441.3%

Operating Cash Flow

$52.55M

-594.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ACADACADIA Pharmaceuticals Inc.

ACADACADIA Pharmaceuticals Inc.$21.40-3.12%

LGNDLigand Pharmaceuticals Incorporated

LGNDLigand Pharmaceuticals Incorporated$213.21-2.63%

DYNDyne Therapeutics, Inc.

DYNDyne Therapeutics, Inc.$17.29-5.42%

SLNOSoleno Therapeutics, Inc.

SLNOSoleno Therapeutics, Inc.$53.01+0.04%

RAREUltragenyx Pharmaceutical Inc.

RAREUltragenyx Pharmaceutical Inc.$25.00-3.10%

MIRMMirum Pharmaceuticals, Inc.

MIRMMirum Pharmaceuticals, Inc.$102.19-8.26%

ADMAADMA Biologics, Inc.

ADMAADMA Biologics, Inc.$8.27-2.71%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDANvidia

NVDANvidia$225.32-0.04%

ONDSOndas

ONDSOndas$10.62-0.05%

INTCIntel

INTCIntel$108.77-0.06%

NOKNokia

NOKNokia$13.95-0.04%

FFord Motor Company

FFord Motor Company$13.40-0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

Questions About TLX

What is the current price of Telix Pharmaceuticals?

Telix Pharmaceuticals is trading at $10.56 per share.

What is the 52-week range for Telix Pharmaceuticals?

Over the past 52 weeks, Telix Pharmaceuticals has traded between $6.28 and $18.49.

How much debt does Telix Pharmaceuticals have?

As of the most recent reporting period, Telix Pharmaceuticals reported total debt of $467.11M.

How much cash does Telix Pharmaceuticals have on hand?

Telix Pharmaceuticals reported $141.87M in cash and cash equivalents in its most recent financial results.

What is Telix Pharmaceuticals’s dividend yield?

Telix Pharmaceuticals does not currently have a dividend yield.

Telix Pharmaceuticals

Telix Pharmaceuticals Financials at a Glance

TLX News

1 Basically Unknown Stock That Could Turn Cancer‑Imaging Breakthroughs Into Generational Wealth

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Telix Pharmaceuticals

TLX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Telix Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TLX

What is the current price of Telix Pharmaceuticals?

What is the 52-week range for Telix Pharmaceuticals?

How much debt does Telix Pharmaceuticals have?

How much cash does Telix Pharmaceuticals have on hand?

What is Telix Pharmaceuticals’s dividend yield?

Premium Investing Services